18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the potential and feasibility of
18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with
neural crest and neuroendocrine tumors.